Perimenopause, Depression, and Ketamine: What Midlife Women Should Know

Menopause is finally getting the attention it was denied for decades. Bookshelves, podcasts, and a wave of new clinics are talking openly about hot flashes, sleep, and hormone therapy. What still gets less airtime is the part that brings many women into my practice: the mood. Not just feeling down, but a new irritability, a flat grey fog, anxiety that shows up out of nowhere, and a depression that does not always respond the way it did in your thirties.

I am a physician who treats depression and anxiety, and I want to talk plainly about where the menopause transition, mood, and ketamine intersect. This is not a claim that ketamine is a hormone treatment or a cure for menopause. It is a careful answer to a question I hear more and more often: my mood fell apart around perimenopause, my usual antidepressant is not doing enough, and I am wondering what else is real.

Perimenopausal depression is real, and it is common

The years leading up to your final period, the phase called perimenopause, are a window of unusual vulnerability for mood. This is not a personality flaw or a failure of resilience. It is biology. A systematic review and meta-analysis found that close to one in three women experiences depressive, anxiety, or insomnia symptoms around the menopause transition (PubMed 41946603). Studies of clinically meaningful depressive symptoms during perimenopause commonly land in the range of 15 to 30 percent, and some cohorts report even higher (PMC11159580).

The driver is not simply that estrogen is low. It is that estrogen is unpredictable. During perimenopause hormone levels swing rather than settle, and the brain, which uses estrogen to help regulate serotonin and norepinephrine, gets a chaotic signal. As estrogen fluctuates and then declines, the systems that steady mood lose a stabilizer they had relied on for thirty years (PMC11159580). This is why perimenopausal depression often does not look like classic sadness. It looks like irritability, brain fog, anxiety, a short fuse, and disrupted sleep. The insomnia and the mood feed each other, which is one reason I take the sleep piece of this so seriously.

If you have felt like a different person over the last couple of years and no one connected it to the transition, you are not imagining it, and you are far from alone.

Why first-line treatment sometimes falls short here

The standard first move for depression is an SSRI, and SSRIs do help many perimenopausal women. But the picture in this specific population is more nuanced than the pamphlet suggests. Reviews of perimenopausal depression describe SSRIs as helpful yet limited by a slow onset and a relatively low remission rate, and they note that adding estrogen to an antidepressant can outperform either treatment alone for symptoms that are truly hormone driven (PMC11159580).

That has fed a real debate you may have seen in the menopause conversation online: whether hormone therapy, not an antidepressant, should be the first-line treatment when low mood is rooted in the hormonal shift itself (The 'Pause Life). I think the honest answer is that it depends on the woman. Hormone therapy is a legitimate and often excellent option, and if your symptoms are tightly linked to the transition, that is a conversation worth having with a menopause-literate clinician or your gynecologist. Some women do beautifully on it.

But there is a group this does not fully cover. Women whose depression persists even with hormone therapy on board. Women for whom hormone therapy is not appropriate or not wanted. And women whose depression started long before perimenopause and simply got worse. When first-line and second-line options have been tried and the depression is still there, the label for that is treatment-resistant depression, and that is the doorway where ketamine becomes a serious topic rather than a fringe one. If you are in that group, my piece on why ketamine works when antidepressants have not is the deeper background.

Where ketamine actually fits, and what the evidence says

Here is the part I want to be careful and honest about, because midlife women have been sold enough hype.

Ketamine works through a completely different pathway than SSRIs. Rather than slowly nudging serotonin, it acts on the glutamate system and appears to rapidly promote new synaptic connections. That mechanistic difference matters in this context, because the serotonin and norepinephrine systems are exactly the ones destabilized by fluctuating estrogen. A treatment that does not depend on that pathway is at least theoretically well suited to depression that arrives with the hormonal transition. You can read the fuller mechanism in how ketamine works for treatment-resistant depression.

The most directly relevant clinical data comes from the Canadian Rapid Treatment Center of Excellence, which looked specifically at menopausal status and response to intravenous ketamine in treatment-resistant depression. Both premenopausal and postmenopausal women responded at similar rates, roughly 30 and 26 percent respectively after four infusions, with matching remission rates, which tells us menopausal status did not blunt the benefit. Notably, postmenopausal women experienced a more rapid reduction in suicidal ideation (PubMed 32948309). Preclinical work has gone further, examining how estrogen and ketamine interact in the brain and why women may be particularly responsive (Gagne et al., Front Psychiatry 2021).

Now the honest limits. That headline study used intravenous ketamine in a clinic, while at-home programs like mine use sublingual dosing, which is a different route at different doses. Direct randomized trials in perimenopause specifically, as opposed to postmenopause or mixed adult samples, are still thin. So the responsible framing is not that ketamine is a proven menopause treatment. It is that ketamine is a well-studied option for treatment-resistant depression, the available evidence shows menopausal status does not reduce its benefit, and the mechanism is a reasonable fit for mood that hormones have destabilized. That is a real, grounded reason for hope, stated without inflating it.

Ketamine also does not treat hot flashes, night sweats, or the physical symptoms of menopause. It treats the depression and anxiety that can ride along with the transition. It is a complement to good menopause care, not a substitute for it.

What this looks like in a monitored at-home program

If you and your clinician decide ketamine is worth trying, the structure around it matters as much as the medicine. A responsible program starts with a real evaluation, screens your blood pressure and cardiac and psychiatric history, and takes a careful medication list, because this stage of life often comes with more prescriptions than the last. We talk about your other treatments rather than around them, and I actively coordinate with, rather than replace, the clinician managing your hormones or gynecologic care. If you want to see the conditions I actually screen for, they are in ketamine contraindications.

Because sleep and anxiety are so tangled into perimenopausal mood, I pay attention to the whole picture, not just a depression score. Sessions are structured with attention to set, setting, and the rest-of-day and next-day activity restrictions, and the real work often happens in the integration afterward. And because rapid relief of dark thoughts is one of the most striking things ketamine can do, I want any woman in crisis to know that ketamine's rapid effect on suicidal ideation is one of its best-documented properties, though acute danger always warrants emergency care first.

Before you try it: three honest questions

First, has your mood change been evaluated in the context of the transition at all. If no one has connected the dots, start there, because sometimes hormone therapy alone is the cleaner answer.

Second, have you actually reached treatment resistance, meaning first-line options were genuinely tried at a real dose for a real duration and did not get you well. Ketamine shines specifically when the standard road has not worked, and you can compare the trade-offs in ketamine versus antidepressants.

Third, do you have a clinician you can reach who will monitor you and coordinate with the rest of your care. That is the difference between medicine and a mail-order product, and at this stage of life, with more moving parts, it matters more, not less.

The menopause conversation has finally grown up enough to talk about the body. The mood deserves the same seriousness. For the women whose depression has not lifted with the usual tools, ketamine is a legitimate, evidence-informed option worth an honest conversation.

Frequently Asked Questions

Is depression during perimenopause a real medical condition?

Yes. Depressive and anxiety symptoms affect a large share of women during the menopause transition, with meta-analysis data suggesting close to one in three women experience depression, anxiety, or insomnia symptoms in this window. Fluctuating and declining estrogen destabilizes the brain systems that regulate mood, which is why symptoms can appear or worsen even in women with no prior history.

Why isn't my usual antidepressant working as well during perimenopause?

SSRIs still help many women, but research in perimenopausal depression describes a slower onset and a lower remission rate in this population, and finds that adding estrogen to an antidepressant can work better than either alone for hormone-driven symptoms. If first-line and second-line treatments have not gotten you well, that is the definition of treatment-resistant depression, which is where options like ketamine enter the conversation.

Does ketamine work for women who are perimenopausal or postmenopausal?

The most directly relevant study found that postmenopausal and premenopausal women responded to intravenous ketamine for treatment-resistant depression at similar rates, so menopausal status did not reduce the benefit, and postmenopausal women saw a faster drop in suicidal ideation. Direct trials focused only on perimenopause are still limited, so ketamine is best understood as a well-studied treatment for treatment-resistant depression that appears to work regardless of menopausal stage, not as a proven menopause therapy.

Is ketamine a replacement for hormone therapy?

No. Ketamine does not treat hot flashes, night sweats, or the physical symptoms of menopause, and it is not a hormone. It treats depression and anxiety. For many women the best plan is coordinated care, where hormone therapy managed by a menopause-literate clinician and ketamine for persistent depression can complement each other rather than compete.

Can I do ketamine therapy if I am already on other midlife medications?

Often yes, but it requires a careful review. This stage of life frequently comes with more prescriptions, and some, such as benzodiazepines, can blunt ketamine's effect while others matter for safety. A legitimate program takes a full medication history, screens your blood pressure and cardiac and psychiatric history, and coordinates with your other clinicians before starting.

---

Sources: Prevalence of depressive, anxiety, and insomnia symptoms in perimenopausal and postmenopausal women, systematic review and meta-analysis (PubMed 41946603); The perimenopause, depressive disorders, and hormonal variability (PMC11159580); Intravenous ketamine for postmenopausal women with treatment-resistant depression, Canadian Rapid Treatment Center of Excellence (PubMed 32948309); Depression, Estrogens, and Neuroinflammation: a preclinical review of ketamine for mood disorders in women, Gagne et al., Front Psychiatry 2021 (PMID 35115970); SSRIs vs hormone therapy as first-line for perimenopausal depression, The 'Pause Life.